期刊文献+

Fas配体基因导入对大鼠颈动脉损伤后新生内膜的影响

Effects of adenoviral vector-mediated Fas ligand gene introduction on neointima after rat carotid injury
下载PDF
导出
摘要 目的 :探讨腺病毒载体介导 Fas配体 (Fas L)基因导入对大鼠颈动脉损伤后新生内膜的影响。方法 :利用重组腺病毒载体将 Fas L 导入大鼠颈动脉球囊损伤的内膜 ,14d后观察其对新生内膜形成的影响。结果 :通过腺病毒载体介导导入 Fas L 基因的被球囊损伤的大鼠颈动脉 ,与 Ad- β gal基因的对照组相比较 ,14d后损伤血管新生内膜 /中膜面积比降低了 73%(P<0 .0 1)。结论 :Fas L 可抑制新生内膜的增生。 AIM: To study the effects of Fas ligand(FasL) gene transfer mediated by adenoviral vector on neointimal hyperplasia after rat carotid injury. METHODS: Restenosis model was established in SD rat and FasL gene was transduced into the carotid artery by adenoviral vector after carotid balloon injury and neointimal/media area ratio in local artery 14 days after gene tranafer was measured. RESULTS: FasL gene was successfully transducted into the carotid artery after balloon injury. Neointimal/media area ratio was reduced 73% (P<0.01) compared with the control group β gal 14 days after gene transfer. CONCLUSION: FasL gene transfer to the vessel wall inhibits neointimal formation. It is an effective gene therapy to restenosis.
出处 《心脏杂志》 CAS 2003年第4期308-310,共3页 Chinese Heart Journal
关键词 FAS配体 血管内膜增生 腺病毒 基因疗法 Fas ligand neointimal hyperplasia adenovirus vecter gene therapy
  • 相关文献

参考文献8

  • 1孙宝华.细胞凋亡信号转导中的蛋白水解酶[J].国外医学(分子生物学分册),1999,21(1):1-5. 被引量:20
  • 2Editorial. possible uses of gene therapy in reducing coronary restenosis[J]. Heart, 1997,78 :426--428.
  • 3Schwartz RS, Holmes DRJ, Topol EJ. The restenosis paradigm revisit :alternative proposal for celluar mechanisms (Editorial) [J]. J Am Coll Cardiol, 1992,20 : 1284-- 1293.
  • 4Serruys PW, de JP,Kiemenei JF. A Comparison of balloon-ex-pandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group[J]. N Engl J Med, 1994,331:489--495.
  • 5Faxon DP ,Sanborn TA,Haudensehild CC. Mechanism of angioplasty and its relation to restenosis[J]. Am J Cardiol, 1987, 60:58--98.
  • 6Walsh K ,Perlman H,Molecular strategies to inhibit restenosis : modulation of the vascular myocyte phenotype[J]. Semin Intervent Cardiol, 1996,1: 172-- 179.
  • 7Chen YH, Jame M. FasLigand : double-edged sword nature[J].Biotechnology, 1998,16 : 1011-- 1012.
  • 8Sara M,Perlman H,Muruve DA, et al.FasLigand gene transfer to the vessel wall inhibits neointimal formation and overrides the adenovirus-mediated T cell response [J]. Proc Nad Acad USA, 1998, 95:1213--1217.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部